What's New

More

RSS

2016.01.29
Finances
 
Posted Conference Call for Third Quarter Financial Results for FY2015 [Webcast]
2016.01.27
Finances
PDF/1385KB
Presentation Material (Third Quarter Financial Results for FY2015)
2016.01.27
Finances
PDF/549KB
Supplementary Financial Data for the Third Quarter of the Year Ending March 31, 2016
2016.01.27
Finances
PDF/330KB
Summary of Consolidated Financial Results for the Third Quarter of the Year Ending March 31, 2016 [Japanese GAAP] (Unaudited)
2016.01.25
R&D
PDF/57KB
Boston Biomedical’s Investigational Cancer Stem Cell Pathway Inhibitor, Napabucasin (BBI608), Featured at the ASCO 2016 Gastrointestinal Cancers Symposium
2016.01.25
R&D
PDF/229KB
Sunovion Announces Results from a Study Evaluating the Abuse Potential of Investigational Drug Dasotraline